WO2007079173A3 - Nouveaux dérivés de 2-hétéroaryloxyphénol au titre d'agents antibactériens - Google Patents

Nouveaux dérivés de 2-hétéroaryloxyphénol au titre d'agents antibactériens Download PDF

Info

Publication number
WO2007079173A3
WO2007079173A3 PCT/US2006/049473 US2006049473W WO2007079173A3 WO 2007079173 A3 WO2007079173 A3 WO 2007079173A3 US 2006049473 W US2006049473 W US 2006049473W WO 2007079173 A3 WO2007079173 A3 WO 2007079173A3
Authority
WO
WIPO (PCT)
Prior art keywords
heteroaryloxy
novel
antibacterial agents
phenol derivatives
methods
Prior art date
Application number
PCT/US2006/049473
Other languages
English (en)
Other versions
WO2007079173A2 (fr
Inventor
Liren Huang
Joanna Clancy
Christopher Taylor
Weitao Pan
Alenka Tomazic
W James Jackson
Original Assignee
Emergent Biosolutions Inc
Liren Huang
Joanna Clancy
Christopher Taylor
Weitao Pan
Alenka Tomazic
W James Jackson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emergent Biosolutions Inc, Liren Huang, Joanna Clancy, Christopher Taylor, Weitao Pan, Alenka Tomazic, W James Jackson filed Critical Emergent Biosolutions Inc
Publication of WO2007079173A2 publication Critical patent/WO2007079173A2/fr
Publication of WO2007079173A3 publication Critical patent/WO2007079173A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne des composés et préparations antimicrobiens et des méthodes de traitement par administration desdits composés et préparations, lesdits composés étant des dérivés de 2-hétéroaryloxyphénol. La présente invention concerne également des méthodes de synthèse et de formation desdits composés, lesdits composés étant de façon générale de Formule 1.
PCT/US2006/049473 2005-12-30 2006-12-29 Nouveaux dérivés de 2-hétéroaryloxyphénol au titre d'agents antibactériens WO2007079173A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85333405P 2005-12-30 2005-12-30
US60/853,334 2005-12-30

Publications (2)

Publication Number Publication Date
WO2007079173A2 WO2007079173A2 (fr) 2007-07-12
WO2007079173A3 true WO2007079173A3 (fr) 2007-11-15

Family

ID=38228847

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/049473 WO2007079173A2 (fr) 2005-12-30 2006-12-29 Nouveaux dérivés de 2-hétéroaryloxyphénol au titre d'agents antibactériens

Country Status (1)

Country Link
WO (1) WO2007079173A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
US9394285B2 (en) 2013-03-15 2016-07-19 Pfizer Inc. Indole and indazole compounds that activate AMPK

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201008209D0 (en) * 2010-05-17 2010-06-30 Senexis Ltd Compounds

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4266063A (en) * 1979-12-17 1981-05-05 E. I. Du Pont De Nemours And Company Process for preparing substituted pyridinyloxy ether intermediate
US5186735A (en) * 1986-03-07 1993-02-16 Dowelanco Derivatives of 4-((aryloxy)phenoxy)alkenols and their herbicidal uses
US6281226B1 (en) * 1997-10-29 2001-08-28 Smithkline Beecham P.L.C. Pleuromutilin derivatives as antimicrobials
US20030114674A1 (en) * 2000-04-04 2003-06-19 Gerald Brooks 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
US6946458B2 (en) * 1999-07-22 2005-09-20 University Of South Florida N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus
US6951880B2 (en) * 2002-05-16 2005-10-04 Genelabs Technologies, Inc. Aryl and heteroaryl compounds as antibacterial and antifungal agents

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4266063A (en) * 1979-12-17 1981-05-05 E. I. Du Pont De Nemours And Company Process for preparing substituted pyridinyloxy ether intermediate
US5186735A (en) * 1986-03-07 1993-02-16 Dowelanco Derivatives of 4-((aryloxy)phenoxy)alkenols and their herbicidal uses
US6281226B1 (en) * 1997-10-29 2001-08-28 Smithkline Beecham P.L.C. Pleuromutilin derivatives as antimicrobials
US6946458B2 (en) * 1999-07-22 2005-09-20 University Of South Florida N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus
US20030114674A1 (en) * 2000-04-04 2003-06-19 Gerald Brooks 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
US6951880B2 (en) * 2002-05-16 2005-10-04 Genelabs Technologies, Inc. Aryl and heteroaryl compounds as antibacterial and antifungal agents

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
US9394285B2 (en) 2013-03-15 2016-07-19 Pfizer Inc. Indole and indazole compounds that activate AMPK

Also Published As

Publication number Publication date
WO2007079173A2 (fr) 2007-07-12

Similar Documents

Publication Publication Date Title
WO2007067559A3 (fr) Agents antibacteriens
WO2006032342A3 (fr) Medicament contenant des composes carbonyles et leur utilisation
WO2004074244A3 (fr) Composes de pyrimidine
GEP20115174B (en) Triazolopyrazine derivatives useful as anti-cancer agents
WO2006120563A3 (fr) Agents antibacteriens
TW200716519A (en) Benzoyl-substituted serineamides
WO2006073457A3 (fr) Composes bioactifs et procedes de leur utilisation
WO2006005609A3 (fr) Derives d'oxindole substitues, et medicaments les renfermant
WO2007148185A3 (fr) 3-amino-pyrrolidino-4-lactames substitués
WO2007064954A3 (fr) Analogues d'aminoglycoside 4,5-substitués antibactériens comportant plusieurs substituants
WO2006099943A8 (fr) 8-n-benzimidazoles a substitution amide, leur procede de production, et leur utilisation en tant que medicaments
WO2007120980A3 (fr) Composés de 2,4-pyrimidinediamine pour le traitement ou la prévention de maladies autoimmunes
WO2007001335A3 (fr) Derives de la ramoplanine presentant une activite antibacterienne
WO2007126900A3 (fr) Agents antifongiques
WO2007066336A3 (fr) Derives chimiques de jasmonate, compositions pharmaceutiques et procedes d’utilisation correspondants
WO2002102793A3 (fr) Agents antibacteriens
WO2006055070A3 (fr) Nouveaux derives de lincomycine possedant une activite anti-microbienne
WO2007066337A3 (fr) Derives chimiques ameliores de jasmonate, compositions pharmaceutiques et procedes d'utilisation correspondants
WO2007009724A3 (fr) Derives de pyrazoline substitues cycloalkane, fabrication et utilisation comme medicaments
WO2010047737A3 (fr) Composés indoliniques antimicrobiens pour le traitement d'infections bactériennes
WO2006077024A3 (fr) Derives de 5-aminoindole
WO2006088903A3 (fr) Composes pyrazole
WO2007131907A3 (fr) Dérivés de 1h-indol-5-yl-pipérazin-1-yl-méthanone
WO2008071961A8 (fr) Dérivés de 2-quinolinone et de 2-quinoxalinone et leur utilisation en tant qu'agents antibactériens
WO2007138112A3 (fr) Composés interagissant avec des canaux ioniques, notamment des canaux ioniques de la famille kv

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06848269

Country of ref document: EP

Kind code of ref document: A2